Clarence L. Dellio
No más puestos en curso
Perfil
Clarence L.
Dellio served as Vice President-Manufacturing at Becton, Dickinson & Co. He then worked as Chief Operating Officer & Senior Vice President at XOMA Corp.
from 1984 to 2004.
From 2004 to 2008, he was the President & Chief Operating Officer at Neosil, Inc. In 2011 to 2013, he served as Chief Operating Officer at Aevi Genomic Medicine, Inc. Mr. Dellio obtained his undergraduate degree from Bentley University.
Antiguos cargos conocidos de Clarence L. Dellio.
Empresas | Cargo | Fin |
---|---|---|
AEVI GENOMIC MEDICINE, INC. | Director de Operaciones | 31/12/2013 |
Neosil, Inc.
Neosil, Inc. Pharmaceuticals: MajorHealth Technology Neosil, Inc. manufactures pharmaceutical products. It develops hair growth products and anti-microbial agent for acne and anti-infective use. The company was founded by Sam Sawan in 2004 and is headquartered in Emeryvill, CA. | Presidente | - |
XOMA CORPORATION | Director de Operaciones | 01/01/2004 |
BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - |
Formación de Clarence L. Dellio.
Bentley University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
XOMA CORPORATION | Health Technology |
BECTON, DICKINSON AND COMPANY | Health Technology |
Empresas privadas | 2 |
---|---|
Neosil, Inc.
Neosil, Inc. Pharmaceuticals: MajorHealth Technology Neosil, Inc. manufactures pharmaceutical products. It develops hair growth products and anti-microbial agent for acne and anti-infective use. The company was founded by Sam Sawan in 2004 and is headquartered in Emeryvill, CA. | Health Technology |
Aevi Genomic Medicine, Inc.
Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Clarence L. Dellio